Global Specimen Collection Cards Market Insights Forecasts to 2033

• The Global Specimen Collection Cards Market Size was Valued at USD 426.02 Million in 2023
• The Market Size is Growing at a CAGR of 5.11% from 2023 to 2033
• The Worldwide Specimen Collection Cards Market Size is Expected to Reach USD 701.02 Million by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

 

Get more details on this report -

Request Free Sample PDF

The Global Specimen Collection Cards Market Size is Anticipated to Exceed USD 701.02 Million by 2033, Growing at a CAGR of 5.11% from 2023 to 2033.

 

Market Overview

Specimen collection cards are used to maintain sample integrity during the collection, storage, and transportation of biological samples for laboratory analysis. The need for diagnostic equipment has increased as infectious diseases are becoming increasingly common globally. For example, according to the National Institute of Health (NIH), infectious diseases account for approximately 52 million deaths worldwide and provide a serious threat to global health. As a result, the rising incidence of infectious diseases emphasizes how critical it is to recognize and treat them as soon as possible. Consequently, specimen collection cards provide a safe and practical way to gather, move, and store samples, enabling effective disease monitoring and management. Additionally, the efficiency and efficacy of specimen collection cards in keeping different biological samples are improved by continuous technical developments in these cards. Furthermore, these cards' innovative designs, constructions, and coatings enhance sample stability, enabling more trustworthy laboratory testing. Additionally, ongoing technological advancements in these cards enhance their effectiveness and efficiency in collecting specimens for the purpose of preserving various biological samples. Meanwhile, the innovative structures, coatings, and patterns of these cards improve sample stability, allowing for more reliable laboratory testing. Moreover, the market's expansion is linked to the growing emphasis on well-being programs, genetic testing, personalized treatment, and health monitoring.

 

Report Coverage

This research report categorizes the market for the global specimen collection cards market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global specimen collection cards market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global specimen collection cards market.

 

Driving Factors

Its efficiency in transporting the specimen or sample gathered is one of the key factors propelling the market for specimen collection cards. The essential chemical and biological data are contained in the specimen or sample that was collected and recorded on the collection card. Therefore, it becomes imperative that the collected specimen's chemical and biological properties remain intact during transportation. Additionally, the expansion of the specimen collection card is being driven by a rise in people's awareness of the need for routine checkups. People prefer to have their blood, urine, and other fluids from their bodies tested at laboratories to receive an early diagnosis of any infection in the body; in order to do this, they require a specimen collection card. Specimen collection cards are necessary for conducting research in the medical and pharmaceutical fields, which is one of the main reasons for their market demand.

 

Restraining Factors

The problems with sample integrity and storage are the primary issues limiting the industry. For testing results to be accurate, the quality and stability of the samples that were gathered must be maintained. The contamination of samples can result from a variety of sources, such as chemicals, bacteria, and environmental pollutants, and can cause false positives or negatives in tests. These factors restrain the growth of the specimen collection cards market.

 

Market Segmentation

The global specimen collection cards market share is classified into product, specimen, and end user.

 

• The cotton & cellulose-based segment is anticipated to hold the largest share of the global specimen collection cards market during the forecast period.    

On the basis of the product, the global specimen collection cards market is divided into cotton & cellulose-based, fiber-based, and other. Among these, the cotton & cellulose-based segment is anticipated to hold the largest share of the global specimen collection cards market during the forecast period. These cards provide better absorption effects, confirming efficient sample collection and preservation. In addition, their affinity with a diverse range of biological specimens, linked to eco-friendly attributes, has propelled worldwide adoption. Furthermore, the prominence of sustainability in healthcare practices has further driven the dominance of the cotton & cellulose-based segment, making it the first choice and the main factor influencing market growth.

 

• The blood segment is anticipated to hold the highest share of the global specimen collection cards market during the forecast period.    

On the basis of the specimen, the global specimen collection cards market is divided into blood, saliva, urine, and buccal cell. Among these, the blood segment is anticipated to hold the highest share of the global specimen collection cards market during the forecast period. Blood specimens stand as a keystone in diagnostic testing, and specimen collection cards adjusted for blood samples have shown better credibility and harmony. The vital role of blood in various medical analyses, combined with the ease and efficiency of using specimen collection cards for blood-related diagnostics, has led to widespread adoption. This segment's dominance is further strengthened by the continuous demand for complete diagnostic solutions, coagulating its position as the factor influencing the expansion of the market.

 

• The hospitals & clinics segment is anticipated to hold the largest share of the global specimen collection cards market during the forecast period.

 On the basis of end user, the global specimen collection cards market is divided into hospitals & clinics, diagnostics centers, and others. Among these, the hospitals & clinics segment is anticipated to hold the largest share of the global specimen collection cards market during the forecast period. The supremacy of the segment is attributed to its high patient impression, different testing requirements, and adherence to quality standards. These organizations play an important role in diagnostics, utilizing specimen collection cards for diverse tests. Additionally, centralized testing facilities, compacted into larger healthcare networks, and collaboration in research further increase their influence, making hospital main drivers of demand for specimen collection cards in the market.

 

Regional Segment Analysis of the Global Specimen Collection Cards Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the largest share of the global specimen collection cards market over the predicted timeframe.

 

Get more details on this report -

Request Free Sample PDF

North America is anticipated to hold the largest share of the global specimen collection cards market over the predicted timeframe. This is explained by the increasing requirement for drug profile for a variety of drugs, including antibiotics, immunosuppressants, and antiepileptics. It is a major driver of the market's expansion. Other factors that are expected to support market growth in this region include the existence of a well-established healthcare infrastructure and the availability of government funding for research. Additionally, the U.S. has taken a high perch in the market because of its up-to-date healthcare facilities, leadership in medical research, and strict adherence to regulatory standards. Moreover, the incorporation of healthcare networks eases the systematic utilization of specimen collection cards, combining the U.S. position as a main driver of demand and invention in the market. These factors drive the growth of the specimen collection cards market over the predicted timeframe in North America.   

 

Asia Pacific is anticipated to grow at the fastest rate in the global specimen collection cards market over the predicted timeframe. The main factor is that the large and assorted population and increasing healthcare awareness in this region have led to increased demand for medical services and diagnostics. Additionally, the fast economic growth in many countries in Asia Pacific has led to expanded investments in healthcare and research. As net profit increases, individuals and governments attribute more funds to improving healthcare results, enlarging the medical technology and device market, such as specimen collection cards. Furthermore, the region has observed significant inventions in medical research and biotechnology, further propelling the demand for specimen collection cards to support diverse studies and clinical trials.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global specimen collection cards market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• PerkinElmer Inc.
• Danaher Corporation
• Ahlstrom
• GenTegra LLC
• CENTOGENE N.V.
• QIAGEN
• DBS System SA
• Eastern Business Forms, Inc.
• ARCHIMED Life Science GmbH
• FortiusBio
• GenoTech Innovations Inc.
• PolyTech Research Solutions
• Cytiva
• DBS System SA
• Others

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Recent Developments

 

• In August 2022, Boston Heart Diagnostics Corporation launched an extensive list of tests utilizing dried blood sport collection for different purposes, encompassing cardiovascular risk factors, type 2 diabetes, and wellness evaluation targeting analytical, nutritional, women’s, and men’s health. 

 

• In March 2020, Danaher Corporation adopted General Electric company’s life science division’s Biopharma business. The obtained business control, under the name Cytiva within Danaher, performs as an independent operating company within Danaher’s Life Sciences segment. This strategic move gave Danaher Corporation a clear competitive advantage in the Life Sciences sector.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global specimen collection cards market based on the below-mentioned segments: 

 

Global Specimen Collection Cards Market, By Product

• Cotton & Cellulose-based
• Fiber-based
• Other

 

Global Specimen Collection Cards Market, By Specimen

• Blood
• Saliva
• Urine
• Buccal Cell

 

Global Specimen Collection Cards Market, By End-User

• Hospitals & Clinics
• Diagnostics Centers
• Other

 

Global Specimen Collection Cards Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa